/* Popup Styles */

About Conference

Infectious Diseases 2027


The 2nd Global Summit on Infectious Diseases is a leading international scientific event committed to promoting excellence in infectious disease research, clinical innovation, and public health. Organized by Times Scientific Group, the conference brings together distinguished experts from universities, hospitals, research institutes, government organizations, pharmaceutical companies, biotechnology industries, and public health agencies in the vibrant city of Tokyo, Japan, on April 26–27, 2027.

Through keynote presentations, plenary lectures, scientific sessions, poster presentations, panel discussions, workshops, and networking events, participants will gain valuable insights into the latest discoveries and technological advances shaping the future of infectious disease research and clinical practice.

Why Attend?

•    Gain insights from internationally renowned keynote speakers and experts. 
•    Present your latest research to a global scientific audience. 
•    Learn about emerging trends and innovative technologies in infectious diseases. 
•    Connect with researchers, clinicians, healthcare professionals, and industry leaders. 
•    Establish new international collaborations and research partnerships. 
•    Enhance your professional development and academic visibility. 
•    Explore publication opportunities in peer-reviewed journals.

Why Tokyo, Japan?

Tokyo stands among the world's foremost centers for scientific innovation, biomedical research, and healthcare excellence. Renowned for its advanced research infrastructure, modern conference and outstanding hospitality, Tokyo offers the perfect destination for an international scientific gathering. Participants will enjoy world-class experiences while engaging in meaningful discussions that shape the future of infectious disease research.

Why Choose Times Scientific Group?

Times Scientific Group is dedicated to advancing scientific excellence by organizing high-quality international conferences that bring together researchers, healthcare professionals, academicians, and industry experts from around the world. Our conferences provide an inclusive platform for knowledge exchange, innovation, networking, and collaboration.

We look forward to welcoming you to Tokyo, Japan, on April 26–27, 2027, for an inspiring and impactful gathering filled with insightful keynote presentations, engaging discussions, valuable networking opportunities, and the exchange of ground-breaking research and innovative ideas.
 

•  Infectious Diseases
•  Infection
•  Clinical Infectious Diseases 
•  Fungal Diseases 
•  Viral Infections 
•  Medical Microbiology 
•  Virology 
•  Bacteriology 
•  Mycology 
•  Antibacterial Research 
•  Parasitology 
•  Antimicrobial Resistance 
•  Antibiotic Stewardship 
•  Immunology 
•  Epidemiology 
•  Zoonotic Diseases 
•  Respiratory Infectious Diseases 
•  HIV/AIDS 
•  Tuberculosis Research 
•  Infection Prevention and Control 
•  Precision Medicine 
•  AI in Infectious Disease Management 
•  Global health 
•  Public health
•  Clinical microbiology 
•  Metagenomics 
•  Pathogen genomics 
•  Microbiome
 

Target Audience

The 2nd Global Summit on Infectious Diseases 2027 brings together a global, multidisciplinary community of experts committed to advancing infectious disease research, prevention, diagnosis, treatment, and public health preparedness. Our delegates represent four key pillars driving innovation and collaboration in infectious diseases.

Research Leaders & Academics

A distinguished gathering of scientists and educators advancing the understanding of infectious diseases through groundbreaking research and scientific discovery.

Senior Faculty: University Professors, Principal Investigators, Department Heads, and Academic Leaders.
Research Experts: Research Scientists, Postdoctoral Fellows, Clinical Researchers, and Scientists from Research Institutes.
Future Innovators: PhD Scholars, Master's Students, Medical Students, and Early-Career Researchers in infectious diseases, microbiology, immunology, and public health.

Healthcare Professionals & Clinical Experts

Frontline healthcare professionals dedicated to improving the prevention, diagnosis, treatment, and management of infectious diseases.

Clinical Specialists: Infectious Disease Physicians, Internal Medicine Specialists, Pediatricians, Pulmonologists, and Critical Care Experts.
Diagnostic Professionals: Clinical Microbiologists, Virologists, Immunologists, Pathologists, Laboratory Scientists, and Diagnostic Specialists.
Healthcare Providers: Nurses, Pharmacists, Infection Prevention & Control Specialists, Hospital Administrators, and Allied Health Professionals.

Public Health Leaders, Policymakers & Global Health Organizations

The decision-makers and public health professionals shaping disease surveillance, outbreak preparedness, and global health policies.

Public Health Authorities: Government Officials, Public Health Officers, Epidemiologists, and Health Policy Advisors.
Global Organizations: Representatives from International Health Agencies, NGOs, Public Health Institutions, and Non-Profit Organizations.
Disease Control Experts: Specialists in Epidemiology, Vaccination Programs, Pandemic Preparedness, and One Health Initiatives.

Industry Leaders & Biotechnology Innovators

The innovators developing next-generation diagnostics, vaccines, therapeutics, and technologies to combat infectious diseases.

Life Sciences Industry: Pharmaceutical, Biotechnology, Vaccine, and Diagnostic Company Executives.
Innovation Leaders: Medical Device Manufacturers, Clinical Trial Professionals, Healthcare Technology Developers, and AI in Healthcare Experts.
Business & Investment: Biotechnology Entrepreneurs, Start-up Founders, Investors, Venture Capitalists, and Business Development Executives focused on healthcare innovation.

Visa Assistance

We are pleased to support international participants attending the 2nd Global Summit on Infectious Diseases in Tokyo, Japan.
Upon successful registration and payment, participants who require a visa to enter japan may request an official Letter of Invitation and other supporting conference documents to assist with their visa application process.

Please note:

  •  Visa approval is solely at the discretion of the respective Embassy or Consulate. 
  •  The conference organizers cannot influence or guarantee visa issuance. 
  •  Participants are encouraged to apply for their visa well in advance of the conference dates. 
  •  Any expenses related to visa applications, travel, accommodation, or embassy requirements are the responsibility of the participant. 
  •  In the event of a visa refusal, refund requests will be handled according to the conference cancellation and refund policy. 
  •  For visa support documents, please contact our organizing committee at [email protected] with your registration details.

Documents Available Upon Registration

  •  Official Letter of Invitation 
  •  Registration Confirmation Receipt
  •  Conference Brochure and Program Details (upon request) 
  •  Accommodation Confirmation (if booked through the organizers) 
  •  This assistance is provided to facilitate the visa application process for registered delegates.

Organizing Panel Members

Mohamed Saleh Al-Hajjaj, Professor and Senior Consultan
University of Sharjah, UAE
Habil. Bernd Blobel
Medical Faculty
University of Regensburg, Germany
Tingzhong Yang
Director of the Research Center for Tobacco Control
Zhejiang University School of Medicine, China
Uqbah bin Muhammad Iqbal
Independent Researcher
Malaysia
Idress Hamad Attitalla
Department of Microbiology , Dean of Faculty of Medical Technology
Omar El-Mukhtar University, Libya

Call for Abstracts

Topics of interest for submission include, but are not limited to the below

  • Infectious Diseases
  • Infection
  • Clinical Infectious Diseases
  • Fungal Diseases
  • Viral Infections
  • Medical Microbiology
  • Virology
  • Bacteriology
  • Mycology
  • Antibacterial Research
  • Parasitology
  • Antimicrobial Resistance
  • Antibiotic Stewardship
  • Immunology
  • Epidemiology
  • Zoonotic Diseases
  • Respiratory Infectious Diseases
  • HIV/AIDS
  • Tuberculosis Research
  • Infection Prevention and Control
  • Precision Medicine
  • AI in Infectious Disease Management
  • Global health
  • Public health
  • Clinical microbiology
  • Metagenomics
  • Pathogen genomics
  • Microbiome
  • Molecular Diagnostics
  • Vaccine Development
Contact

+1 281-968-3414

+1 707-378-6010

» Contact Us
Address

Times Scientific Group
5900 Balcones Drive, STE 100
Austin, TX 78731

+1 (707) 378-6010